Search

Author/Creator Chuang, Wan‐Long

1. 25‐Hydroxy vitamin D suppresses hepatitis C virus replication and contributes to rapid virological response of treatment efficacy. Issue 13 (24th March 2017)

Authors:
Huang, Jee‐Fu; Ko, Yu‐Min; Huang, Chung‐Feng; Yeh, Ming‐Lun; Dai, Chia‐Yen; Hsieh, Meng‐Hsuan; Huang, Ching‐I; Yang, Hua‐Ling; Wang, Shu‐Chi; Lin, Zu‐Yau; Chen, Shinn‐Chern; Yu, Ming‐Lung; Chuang, Wan‐Long
Journal:
Hepatology research
Issue:
Volume 47:Issue 13(2017)
Page Start:
1383
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A Phase 3 clinical trial validating the potency and safety of an innovative, extra‐long‐acting interferon in chronic hepatitis C. Issue 11 (10th October 2022)

Authors:
Chen, Chi‐Yi; Chuang, Wan‐Long; Qin, Albert; Zhang, Wen‐Hua; Zhu, Li‐Ying; Zhang, Guo‐Qiang; Chen, Jyh‐Jou; Lo, Ching‐Chu; Zhou, Xinmin; Mao, Xiaorong; Shang, Jia; Kuo, Hsing‐Tao; Xie, Wen; Chen, Chien‐Hung; Lo, Gin‐Ho; Jun, Dae W; Dang, Shuangsuo; Tsai, Chan‐Yen; Wang, Ting‐Fang; Lai, Hsin‐Hui
Journal:
JGH open
Issue:
Volume 6:Issue 11(2022)
Page Start:
782
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. A phase 3, open‐label study of daclatasvir plus asunaprevir in Asian patients with chronic hepatitis C virus genotype 1b infection who are ineligible for or intolerant to interferon alfa therapies with or without ribavirin. Issue 11 (November 2016)

Authors:
Wei, Lai; Zhang, Mingxiang; Xu, Min; Chuang, Wan‐Long; Lu, Wei; Xie, Wen; Jia, Zhansheng; Gong, Guozhong; Li, Yueqi; Bae, Si Hyun; Yang, Yong‐Feng; Xie, Qing; Lin, Shumei; Chen, Xinyue; Niu, Junqi; Jia, Jidong; Garimella, Tushar; Torbeyns, Anne; McPhee, Fiona; Treitel, Michelle
Journal:
Journal of gastroenterology and hepatology
Issue:
Volume 31:Issue 11(2016:Nov.)
Page Start:
1860
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infection. (23rd March 2016)

Authors:
Kao, Jia‐Horng; Chien, Rong‐Nan; Chang, Ting‐Tsung; Peng, Cheng‐Yuan; Hu, Tsung‐Hui; Lo, Gin‐Ho; Wang, Horng‐Yuan; Chen, Jyh‐Jou; Yang, Jenny C.; Knox, Steven J.; Han, Lingling; Mo, Hongmei; Mathias, Anita; Brainard, Diana M.; Sheen, I‐Shyan; Hsu, Yu‐Chun; Chu, Chi‐Jen; Chuang, Wan‐Long
Journal:
Liver international
Issue:
Volume 36:Number 8(2016)
Page Start:
1101
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. A real‐world impact of cost‐effectiveness of pegylated interferon/ribavarin regimens on treatment‐naïve chronic hepatitis C patients in Taiwan. Issue 1 (18th November 2016)

Authors:
Tsai, Pei‐Chien; Liu, Ta‐Wei; Hsieh, Meng‐Hsuan; Yeh, Ming‐Lun; Liang, Po‐Cheng; Lin, Yi‐Hung; Huang, Ching‐I; Huang, Chung‐Feng; Hsieh, Ming‐Yen; Hou, Nai‐Jen; Lin, Zu‐Yau; Chen, Shinn‐Cherng; Huang, Jee‐Fu; Dai, Chia‐Yen; Chuang, Wan‐Long; Yu, Ming‐Lung
Journal:
Kaohsiung journal of medical sciences
Issue:
Volume 33:Issue 1(2017)
Page Start:
44
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Alisporivir plus ribavirin, interferon free or in combination with pegylated interferon, for hepatitis C virus genotype 2 or 3 infection. Issue 4 (10th August 2015)

Authors:
Pawlotsky, Jean‐Michel; Flisiak, Robert; Sarin, Shiv K.; Rasenack, Jens; Piratvisuth, Teerha; Chuang, Wan‐Long; Peng, Cheng‐Yuan; Foster, Graham R.; Shah, Samir; Wedemeyer, Heiner; Hézode, Christophe; Zhang, Wei; Wong, Kelly A.; Li, Bin; Avila, Claudio; Naoumov, Nikolai V.; on behalf of the VITAL...
Journal:
Hepatology
Issue:
Volume 62:Issue 4(2015:Oct.)
Page Start:
1013
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Amelioration of glucose intolerance through directly acting antiviral agents in chronic hepatitis C cirrhotic patients without overt diabetes. Issue 9 (7th June 2022)

Authors:
Jang, Tyng‐Yuan; Lin, Yi‐Hung; Liang, Po‐Cheng; Yeh, Ming‐Lun; Huang, Ching‐I; Liu, Ta‐Wei; Wei, Yu‐Ju; Hsu, Po‐Yao; Yang, Jeng‐Fu; Hou, Nai‐Jen; Wang, Chih‐Wen; Hsieh, Ming‐Yen; Lin, Zu‐Yau; Huang, Chung‐Feng; Huang, Jee‐Fu; Dai, Chia‐Yen; Chuang, Wan‐Long; Yu, Ming‐Lung
Journal:
Kaohsiung journal of medical sciences
Issue:
Volume 38:Issue 9(2022)
Page Start:
897
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗